Literature DB >> 25534560

Molecular genetic analysis of trinucleotide repeat disorders (TRDs) in Indian population and application of repeat primed PCR.

Aneek Das Bhowmik1, Savithri Rangaswamaiah1, G Srinivas1, Ashwin B Dalal2.   

Abstract

Trinucleotide repeat disorders (TRDs) are a set of genetic disorders caused by trinucleotide repeat expansion in certain genes that exceed the normal, stable threshold, which varies from gene to gene. A dynamic mutation in a healthy gene may increase the repeat count and result in a defective gene. At present there are 14 pathogenic trinucleotide repeat disorders that are known to affect humans. The occurrence of these "triplet repeat diseases" within populations ranges from fairly common (Fragile X syndrome and Myotonic dystrophy type 1) to rare (Dentatorubral-pallidoluysian atrophy). In the present study we report a detailed scenario of TRDs in India mostly in respect to the 9 most common disorders namely; Fragile X syndrome, Myotonic dystrophy type 1, Spinocerebellar ataxia (type 1, 2, 3, 6 and 7), Friedreich Ataxia and Huntington Disease.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Fragile X syndrome; Friedreich Ataxia and Huntington Disease; Myotonic dystrophy type 1; Spinocerebellar ataxia; Trinucleotide repeat disorders

Mesh:

Year:  2014        PMID: 25534560     DOI: 10.1016/j.ejmg.2014.12.010

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  2 in total

Review 1.  Evaluating the current state of the art of Huntington disease research: a scientometric analysis.

Authors:  L A Barboza; N C Ghisi
Journal:  Braz J Med Biol Res       Date:  2018-01-11       Impact factor: 2.590

2.  DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder.

Authors:  Aiysha Chaudhry; Alkyoni Anthanasiou-Fragkouli; Henry Houlden
Journal:  J Neurol       Date:  2020-10-26       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.